Table 3 Association of BCVA with Baseline and clinical characteristics patients
| Variable |
LogMAR BCVA Mean (±SD) | P-value |
|---|---|---|
| Sex | ||
| Male | 0.545 (±0.64) | 0.007* |
| Female | 0.873 (±0.84) | |
| RP associated with a syndrome | ||
| Yes | 0.667(±0.67) | 0.340℗ |
| No | 0.661 (±0.75) | |
| CME | ||
| Present | 0.33(±0.22) | < 0.001* |
| Absent | 0.73(±0.79) | |
| Ellipsoid Zone | ||
| Intact | 0.430(±0.55) | |
| Abnormal | 0.408(±0.35) | < 0.001** |
| Absent | 1.13(±0.97) | |
| External Limiting Membrane | ||
| Intact | 0.415(±0.47) | |
| Absent | 1.11(±0.93) | < 0.001** |
| Abnormal | 0.407(±0.39) | |
| ERM | ||
| Present | 0.402 (±0.69) | 0.125℗ |
| Absent | 0.693 (±0.6) | |
| Vitreous hyperreflective foci | ||
| Present | 0.590 (±0.66) | 0.551℗ |
| Absent | 0.684 (±0.69) | |